Digestive System Neoplasms: Clinical Trials

26 trials for Digestive System Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 terminated. 26 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 426Terminated 26

Follow Digestive System Neoplasms: new trials by email Literature Review of Digestive System Neoplasms trials Research Report on Digestive System Neoplasms

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine-assisted Therapy for Advanced GI Cancer
Ketamine, Ketamine Injectable Product, Meaning and Purpose therapy - Pancreatic Ductal Adenocarcinoma, Pain, Acute
Phase 4TerminatedBrian Anderson, MD12024-05-172025-05-21
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
Bevacizumab, Atezolizumab, Sofosbuvir - Liver Cancer
Phase 4TerminatedM.D. Anderson Cancer Center22023-03-172024-12-31
The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.
Indocyanine green - Gastric Cancer
Phase 4TerminatedCopenhagen University Hospital, Rigshospitalet112022-03-112024-05-02
Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases
Gadoxetate disodium, Gadobenate dimeglumine - Oligometastatic Disease, Liver Metastases
Phase 4TerminatedUniversity of Colorado, Denver102021-06-222026-09-25
Nutrition and Pharmacological Algorithm for Oncology Patients Study
Dexamethasone, Dronabinol, Mirtazapine - Oncologic Complications, Quality of Life
Phase 4TerminatedMontefiore Medical Center12021-03-012022-11-16
A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)
Pancrelipase, Placebo - Exocrine Pancreatic Insufficiency (EPI)
Phase 4TerminatedAbbVie12020-02-252023-06-05
A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC
Sodium Glycididazole - Esophageal Neoplasms
Phase 4TerminatedShandong Cancer Hospital and Institute22016-08-012019-10-11
A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC
Sodium Glycididazole - Esophageal Neoplasms
Phase 4TerminatedShandong Cancer Hospital and Institute82016-07-052019-10-11
Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases
Colonic resection, Chemotherapy- scheme - Colonic Cancer, Unresectable Metastasis Originating in Colonic Cancer
Phase 4TerminatedHospital Universitari de Bellvitge1072013-12-012021-03-16
DCE-MRI Using DotaremĀ® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
Gadoterate meglumine - Hepatocellular Carcinoma
Phase 4TerminatedGuerbet372013-05-092019-08-08
HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)
Sorafenib - Hepatocellular Cancer
Phase 4TerminatedMassachusetts General Hospital32013-05-012017-04-19
Radial Reload Laparoscopic LAR Case Series
Covidien Radial Reload Stapler with Tri-Staple Technology - Colorectal Cancer
Phase 4TerminatedMedtronic - MITG82013-04-012015-03-18
Does Administration of Antibiotics in Patients Undergoing Surgery for Colorectal Cancer Result in Less Complications and Better Prognosis?
Selective decontamination of the digestive tract (SDD) (colistin sulfate, tobramycin, amphotericin B) - Colorectal Cancer
Phase 4TerminatedH. Jaap Bonjer, PhD4852013-01-012018-11-09
Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study
Placebo, Pregabalin - Pancreatic Cancer, Visceral Pain
Phase 4TerminatedParc de Salut Mar202012-08-012017-10-06
Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
Huaier Granule - Hepatic Carcinoma
Phase 4TerminatedQidong Gaitianli Medicines Co., Ltd7902011-11-072020-03-06
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Pharmacokinetic 5-FU dose adjustment using OnDoseĀ® assay, Standard of care - Colorectal Cancer, Metastatic
Phase 4TerminatedMyriad Genetic Laboratories, Inc.512011-09-012023-07-19
A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer
trastuzumab [Herceptin] - Gastric Cancer
Phase 4TerminatedHoffmann-La Roche42011-06-012016-11-02
A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
erlotinib [Tarceva], gemcitabine - Pancreatic Cancer
Phase 4TerminatedHoffmann-La Roche62007-08-012016-08-24
Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
cetuximab, bevacizumab - Colorectal Cancer, Neoplasm Metastasis
Phase 4TerminatedHospices Civils de Lyon312006-05-012009-02-09
Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus
Liver resection plus Thrombectomy - Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Phase 4TerminatedSun Yat-sen University1262006-01-012019-01-23

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Colorectal Neoplasms (9)  ·  Pancreatic Neoplasms (4)  ·  Carcinoma, Hepatocellular (3)  ·  Liver Neoplasms (3)  ·  Neoplasm Metastasis (3)  ·  Colonic Neoplasms (2)  ·  Esophageal Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Acute Pain (1)  ·  Adenomatous Polyposis Coli (1)  ·  Anastomotic Leak (1)  ·  Cancer Pain (1)  ·  End Stage Liver Disease (1)  ·  Exocrine Pancreatic Insufficiency (1)  ·  Gastrointestinal Neoplasms (1)

Broader conditions

Digestive System Diseases (26)  ·  Neoplasms (26)  ·  Neoplasms by Site (26)  ·  Gastrointestinal Diseases (16)  ·  Gastrointestinal Neoplasms (15)  ·  Colonic Diseases (11)  ·  Intestinal Diseases (11)  ·  Intestinal Neoplasms (11)  ·  Rectal Diseases (9)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Liver Diseases (5)  ·  Endocrine Gland Neoplasms (4)  ·  Endocrine System Diseases (4)  ·  Neoplasms by Histologic Type (4)

Interventions

Bevacizumab (4)  ·  sodium glycididazole (2)  ·  Amphotericin B (1)  ·  Capecitabine (1)  ·  Cetuximab (1)  ·  Colistin (1)  ·  Dexamethasone (1)  ·  Diet Therapy (1)  ·  Dronabinol (1)  ·  Duration of Therapy (1)  ·  Erlotinib Hydrochloride (1)  ·  FOLFOXIRI protocol (1)  ·  Folfox protocol (1)  ·  Gemcitabine (1)  ·  Hepatectomy (1)

Sponsors

Hoffmann-La Roche (2)  ·  Shandong Cancer Hospital and Institute (2)  ·  AbbVie (1)  ·  Brian Anderson, MD (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Genentech, Inc. (1)  ·  Guerbet (1)  ·  H. Jaap Bonjer, PhD (1)  ·  Hospices Civils de Lyon (1)  ·  Hospital Clinic of Barcelona (1)  ·  Hospital Universitari de Bellvitge (1)  ·  James A. Haley Veterans Administration Hospital (1)  ·  M.D. Anderson Cancer Center (1)  ·  Massachusetts General Hospital (1)  ·  Medtronic - MITG (1)

Countries

United States (11)  ·  China (4)  ·  Spain (3)  ·  Denmark (1)  ·  France (1)  ·  India (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Jinming Yu, Ph.D, M.D (2)  ·  Abebe Haregewoin, MD, PhD (1)  ·  Andrew Zhu, MD, PhD (1)  ·  Brian T Anderson, MD (1)  ·  Carlos Moreno Sanz (1)  ·  Conor Delaney, MD (1)  ·  Eduardo Targarona Soler (1)

Results publications

PMID 21336429, PMID 24814583, PMID 28497402, PMID 30802304, PMID 38412408

NIH funding

2019 (1), P30CA046934 (1)